Cargando…

Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine

Detalles Bibliográficos
Autores principales: Kessler, Alaina J., Para, Andrew, Niedt, George W., Klein, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176165/
https://www.ncbi.nlm.nih.gov/pubmed/37188285
http://dx.doi.org/10.1016/j.jdcr.2023.02.016
_version_ 1785040377557811200
author Kessler, Alaina J.
Para, Andrew
Niedt, George W.
Klein, Paula
author_facet Kessler, Alaina J.
Para, Andrew
Niedt, George W.
Klein, Paula
author_sort Kessler, Alaina J.
collection PubMed
description
format Online
Article
Text
id pubmed-10176165
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101761652023-05-13 Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine Kessler, Alaina J. Para, Andrew Niedt, George W. Klein, Paula JAAD Case Rep Case Report Elsevier 2023-03-08 /pmc/articles/PMC10176165/ /pubmed/37188285 http://dx.doi.org/10.1016/j.jdcr.2023.02.016 Text en © 2023 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Kessler, Alaina J.
Para, Andrew
Niedt, George W.
Klein, Paula
Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine
title Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine
title_full Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine
title_fullStr Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine
title_full_unstemmed Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine
title_short Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine
title_sort anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176165/
https://www.ncbi.nlm.nih.gov/pubmed/37188285
http://dx.doi.org/10.1016/j.jdcr.2023.02.016
work_keys_str_mv AT kessleralainaj antitranscriptionalintermediaryfactor1gantibodypositivedermatomyositisinapatientwithtriplenegativebreastcancertreatedwithadjuvantcapecitabine
AT paraandrew antitranscriptionalintermediaryfactor1gantibodypositivedermatomyositisinapatientwithtriplenegativebreastcancertreatedwithadjuvantcapecitabine
AT niedtgeorgew antitranscriptionalintermediaryfactor1gantibodypositivedermatomyositisinapatientwithtriplenegativebreastcancertreatedwithadjuvantcapecitabine
AT kleinpaula antitranscriptionalintermediaryfactor1gantibodypositivedermatomyositisinapatientwithtriplenegativebreastcancertreatedwithadjuvantcapecitabine